These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Prescription for the Orphan Drug Act: the impact of the FDA's 1992 regulations and the latest congressional proposals for reform. Clissold DB Food Drug Law J; 1995; 50(1):125-47. PubMed ID: 10342989 [No Abstract] [Full Text] [Related]
8. The National Institutes of Health Small Business Innovation Research (SBIR) Program: opportunities for orphan drug development. Engstrom LO Prog Clin Biol Res; 1985; 197():25-30. PubMed ID: 4070295 [No Abstract] [Full Text] [Related]
9. Drugs bill to rein in profits. Gershon D Nature; 1994 Mar; 368(6470):381. PubMed ID: 8133874 [No Abstract] [Full Text] [Related]
10. Bush veto fuels orphan drug act uncertainties. Gershon D Nature; 1990 Nov; 348(6298):185. PubMed ID: 2234086 [No Abstract] [Full Text] [Related]
11. New products highlight ambiguity of orphan drug law. Reid B Nat Biotechnol; 2003 Jan; 21(1):6-7. PubMed ID: 12511896 [No Abstract] [Full Text] [Related]
12. PhRMA sues on 340B orphans. Lee J Mod Healthc; 2013 Oct; 43(40):17. PubMed ID: 24340726 [No Abstract] [Full Text] [Related]
13. Orphan products development and some methods for maximizing the usefulness of research on rare diseases. Finkel MJ Prog Clin Biol Res; 1985; 197():11-8. PubMed ID: 4070285 [No Abstract] [Full Text] [Related]
15. $1 billion drug deal creates debt for "tomorrow's AIDS orphans". Ferriman A West J Med; 2000 Oct; 173(4):228. PubMed ID: 11017974 [No Abstract] [Full Text] [Related]
16. Congress, the FDA, and the fair development of new medications for children. McKinney RE Pediatrics; 2003 Sep; 112(3 Pt 1):669-70. PubMed ID: 12949299 [No Abstract] [Full Text] [Related]
17. Antidote shortages in the USA: impact and response. ; J Med Toxicol; 2015 Mar; 11(1):144-6. PubMed ID: 25711999 [No Abstract] [Full Text] [Related]
18. Orphan drugs: the question of products liability. Scharf SF Am J Law Med; 1985; 10(4):491-513. PubMed ID: 3911776 [TBL] [Abstract][Full Text] [Related]
19. Rare diseases, drug development, and AIDS: the impact of the Orphan Drug Act. Arno PS; Bonuck K; Davis M Milbank Q; 1995; 73(2):231-52. PubMed ID: 7776947 [TBL] [Abstract][Full Text] [Related]
20. The future of orphan drug development. Woodcock J Clin Pharmacol Ther; 2012 Aug; 92(2):146-8. PubMed ID: 22814657 [No Abstract] [Full Text] [Related] [Next] [New Search]